| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| target | Mumps/Parotitis Virus reactive IgM |
| species reactivity | Mumps Virus |
| applications | ELISA |
| assay type | Indirect & quantitative |
| available size | 3 mL |
Mumps-Parotitis Virus IgM Control Serum BC103M
$94.00
Summary
- Virion/Serion Diagnostic Kit Control for research use (RUO)
- Mumps-Parotitis Virus IgM Control Serum
- Applications: ELISA
- IgM control serum
- Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
- 3 mL
Mumps-Parotitis Virus IgM Control Serum BC103M
| kit |
|---|
| Research area Infectious Disease |
| Storage Store at 2-8°C. |
| Associated products Mumps Virus Nucleoprotein Control Antigen (BA103R01) Mumps Virus Antigen (BA103VS) Mumps/Parotitis Virus IgG Control Serum (BC103G) Mumps/Parotitis Virus IgM Control Serum (BC103M) Mumps Virus IgG ELISA Kit (ESR103G) Mumps Virus IgM ELISA Kit (ESR103M) |
| target relevance |
|---|
| Organism Mumps Virus |
| Protein names Mumps Virus |
| Structure and strains Mumps is a viral disease caused by the mumps virus. Initial symptoms of mumps are non-specific and include fever, headache, malaise, muscle pain, and loss of appetite. These symptoms are usually followed by painful swelling of the parotid glands, called parotitis, which is the most common symptom of a mumps infection. Symptoms typically occur 16 to 18 days after exposure to the virus and resolve within two weeks. About one third of infections are asymptomatic. |
| Detection and diagnosis Demonstration of IgM antibodies is commonly used as evidence for an acute infection and provides positive test results early on with the onset of symptoms. The demonstration of IgG antibodies serves primarily for immune status and vaccination control as well as for confirmation of Mumps Virus infections. The detection of IgG antibodies in CSF samples is p |
Data
FAQ & Publications
Frequently Asked Questions
What is the intended application for the Mumps-Parotitis Virus IgM Control Serum BC103M?
This control serum is designed for use in ELISA assays, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays to detect Mumps-Parotitis Virus reactive IgM antibodies.
How should the Mumps-Parotitis Virus IgM Control Serum BC103M be stored to maintain its stability?
The serum should be stored at a temperature of 2-8°C to preserve its integrity and performance.
Is the Mumps-Parotitis Virus IgM Control Serum BC103M ready to use or does it require dilution?
The control serum is provided as ready-to-use and is pre-diluted for use in the specified SERION ELISA assays.
What is the species reactivity of the Mumps-Parotitis Virus IgM Control Serum BC103M?
This control serum is reactive to the Mumps Virus, making it suitable for research involving this particular infectious agent.
What volume is supplied for the Mumps-Parotitis Virus IgM Control Serum BC103M, and is it suitable for quantitative assays?
The product is supplied as a 3 mL volume and is intended for indirect and quantitative ELISA assay formats.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| BC103M protocol |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.